Taken together, these data suggest that in clinical colorectal cancer patients high CXCR4 expression contribute to CRC progression and invasion through recruiting macrophages and upregulation of RhoA by repressing miR-133a-3p. Here, CXCR4 is linked to colorectal carcinoma.